Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Offit

Showing results (11-20 of 429) with videos related to

Pageof 43
Sort By:
Oncology (Williston Park, N.Y.)|June 27, 2012
Genetic testing in gastrointestinal cancers: a case-based approachKasmintan Schrader, Kenneth Offit, Zsofia K Stadler
Current Oncology Reports|August 5, 2004
The genetics of familial lymphomasRina Siddiqui, Kenan Onel, Flavia Facio, et al.
Science (New York, N.Y.)|March 29, 2014
Two decades after BRCA: setting paradigms in personalized cancer care and preventionFergus J Couch, Katherine L Nathanson, Kenneth Offit
The Journal of Molecular Diagnostics : JMD|March 28, 2009
A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencingLiying Zhang, Tomas Kirchhoff, Cindy J Yee, et al.
Oncology (Williston Park, N.Y.)|July 31, 2010
Genome-wide association studies of cancer: principles and potential utilityZsofia K Stadler, David J Gallagher, Peter Thom, et al.
Clinical Colorectal Cancer|October 6, 2010
Diagnosing hereditary colorectal cancerDavid J Gallagher, James D Smith, Kenneth Offit, et al.
Advances in Experimental Medicine and Biology|March 19, 2016
Genomic Biomarkers for Breast Cancer RiskMichael F Walsh, Katherine L Nathanson, Fergus J Couch, et al.
JAMA|September 24, 2004
The "duty to warn" a patient's family members about hereditary disease risksKenneth Offit, Elizabeth Groeger, Sam Turner, et al.
Mutation Research|December 17, 2008
cDNA analysis demonstrates that the BRCA2 intronic variant IVS4-12del5 is a deleterious mutationLiying Zhang, Ruben Bacares, Sherry Boyar, et al.
Familial Cancer|May 2, 2020
Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome familyCiyu Yang, Margaret Sheehan, Ester Borras, et al.
Pageof 43

Showing results (11-20 of 429) with videos related to

Sort By:
Pageof 43
Oncology (Williston Park, N.Y.)|June 27, 2012
Genetic testing in gastrointestinal cancers: a case-based approachKasmintan Schrader, Kenneth Offit, Zsofia K Stadler
Current Oncology Reports|August 5, 2004
The genetics of familial lymphomasRina Siddiqui, Kenan Onel, Flavia Facio, et al.
Science (New York, N.Y.)|March 29, 2014
Two decades after BRCA: setting paradigms in personalized cancer care and preventionFergus J Couch, Katherine L Nathanson, Kenneth Offit
The Journal of Molecular Diagnostics : JMD|March 28, 2009
A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencingLiying Zhang, Tomas Kirchhoff, Cindy J Yee, et al.
Oncology (Williston Park, N.Y.)|July 31, 2010
Genome-wide association studies of cancer: principles and potential utilityZsofia K Stadler, David J Gallagher, Peter Thom, et al.
Clinical Colorectal Cancer|October 6, 2010
Diagnosing hereditary colorectal cancerDavid J Gallagher, James D Smith, Kenneth Offit, et al.
Advances in Experimental Medicine and Biology|March 19, 2016
Genomic Biomarkers for Breast Cancer RiskMichael F Walsh, Katherine L Nathanson, Fergus J Couch, et al.
JAMA|September 24, 2004
The "duty to warn" a patient's family members about hereditary disease risksKenneth Offit, Elizabeth Groeger, Sam Turner, et al.
Mutation Research|December 17, 2008
cDNA analysis demonstrates that the BRCA2 intronic variant IVS4-12del5 is a deleterious mutationLiying Zhang, Ruben Bacares, Sherry Boyar, et al.
Familial Cancer|May 2, 2020
Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome familyCiyu Yang, Margaret Sheehan, Ester Borras, et al.
Pageof 43